MoonLake Immunotherapeutics Class A Ordinary Shares
€16.03
EUR
Last updated on --.
24h volume699.99K
24h highest16.1355 EUR
24h lowest15.6100 EUR
24h Price movement+2.24%
MLTX recent prices
24 Hours
+2.24%+€0.35092
30 days
+10.66%+€1.527
60 days
+8.90%+€1.295
90 days
+5.29%+€0.79645
Key data
Previous close15.6796 EUR
Market cap1.08B EUR
Volume699.99K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-2.9845 EUR
Net income (FY)-223.17M EUR
Revenue (FY)--
Last report dateMay 11, 2026
About MoonLake Immunotherapeutics Class A Ordinary Shares
HeadquartersZUG
Employees (FY)130.00
Net income per employee (FY)-1.72M EUR
Listed onNasdaq
MLTX conversion tables
 |  |
|---|---|
| 0.5 MLTX | 8.015 EUR |
| 1 MLTX | 16.03 EUR |
| 5 MLTX | 80.15 EUR |
| 10 MLTX | 160.3 EUR |
| |
|---|---|
| 0.5 EUR | 0.03119 MLTX |
| 1 EUR | 0.062381 MLTX |
| 5 EUR | 0.3119 MLTX |
| 10 EUR | 0.62381 MLTX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
MLTX is trading at €16.03, +2.24% over the last 24 hours. Track live moves on the price chart at the top of this page.
The MLTX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. MLTX is currently trading at €16.03, +2.24% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on MLTX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. MLTX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from MLTX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against MLTX's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
MoonLake Immunotherapeutics Class A Ordinary Shares's market cap is currently 1.08B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume699.99K
24h highest16.1355 EUR
24h lowest15.6100 EUR
24h Price movement+2.24%
Start trade with MLTX Perpetual
Sign up to trade